- - --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Issuer
PURSUANT to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934
Filing No. 3 for the month of April, 1999
Visible Genetics Inc.
---------------------
(Exact name of Registrant)
700 Bay Street, Suite 1000, Toronto ON, Canada M5G 1Z6
------------------------------------------------------
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports
under cover Form 20-F or Form 40-F
Form 20-F |X| Form 40-F |_|
Indicate by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes |_| No |X|
- - --------------------------------------------------------------------------------
VISIBLE GENETICS INC.
The Company has announced that it has entered into an agreement with
Organon Teknika (OT) whereby OT will be the exclusive distributor in Brazil of
the Company's OpenGene(TM) automated DNA sequencing system and GeneKits(TM). The
agreement is for a period of four years and has provisions that guarantee
minimum annual revenues over that period to the Company
Organon Teknika, a division of Dutch-based Akzo Nobel, has over 25 years
experience in the marketing, sales and support of pharmaceutical and diagnostic
products in Brazil.
On or about April 21, 1999, the Company issued a press release with
respect to the foregoing.
The Company hereby incorporates by reference the text of this Form 6-K
(but not the Exhibit hereto) into the Company's Registration Statements on Form
F-3 (File Nos. 333-67607 and 333-68939).
Exhibit 1. Press release - "Visible Genetics Inc. and Organon Teknika
enter exclusive distribution and marketing agreement for VGI products in
Brazil."
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
VISIBLE GENETICS INC.
Date: April 21, 1999 By: /s/ Jeffrey D. Sherman
------------------------------------------
Name: Jeffrey D. Sherman
Title: Vice President, Finance and C.F.O.
3